Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric I Benchimol

Showing results (221-230 of 276) with videos related to

Pageof 28
Sort By:
Inflammatory Bowel Diseases|February 11, 2026
Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohortAmanda Ricciuto, Andrei L Turinsky, Anne M Griffiths, et al.
The Lancet. Gastroenterology & Hepatology|October 28, 2022
Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel diseaseJoshua Quan, Christopher Ma, Remo Panaccione, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2022
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task ForceShirley V Wang, Anton Pottegård, William Crown, et al.
The American Journal of Gastroenterology|January 13, 2011
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHANDan Turner, Simon P L Travis, Anne M Griffiths, et al.
BMJ (Clinical Research Ed.)|November 16, 2018
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)Sinéad M Langan, Sigrún Aj Schmidt, Kevin Wing, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 26, 2019
Sinéad M Langan, Sigrún A J Schmidt, Kevin Wing, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and RecommendationsSanjay K Murthy, M Ellen Kuenzig, Joseph W Windsor, et al.
The American Journal of Gastroenterology|October 3, 2023
Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort StudyJennifer C deBruyn, Hien Q Huynh, Anne M Griffiths, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2022
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task forceShirley V Wang, Anton Pottegård, William Crown, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel DiseaseEric I Benchimol, Matthew W Carroll, Rose Geist, et al.
Pageof 28

Showing results (221-230 of 276) with videos related to

Sort By:
Pageof 28
Inflammatory Bowel Diseases|February 11, 2026
Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohortAmanda Ricciuto, Andrei L Turinsky, Anne M Griffiths, et al.
The Lancet. Gastroenterology & Hepatology|October 28, 2022
Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel diseaseJoshua Quan, Christopher Ma, Remo Panaccione, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2022
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task ForceShirley V Wang, Anton Pottegård, William Crown, et al.
The American Journal of Gastroenterology|January 13, 2011
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHANDan Turner, Simon P L Travis, Anne M Griffiths, et al.
BMJ (Clinical Research Ed.)|November 16, 2018
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)Sinéad M Langan, Sigrún Aj Schmidt, Kevin Wing, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 26, 2019
Sinéad M Langan, Sigrún A J Schmidt, Kevin Wing, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and RecommendationsSanjay K Murthy, M Ellen Kuenzig, Joseph W Windsor, et al.
The American Journal of Gastroenterology|October 3, 2023
Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort StudyJennifer C deBruyn, Hien Q Huynh, Anne M Griffiths, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2022
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task forceShirley V Wang, Anton Pottegård, William Crown, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel DiseaseEric I Benchimol, Matthew W Carroll, Rose Geist, et al.
Pageof 28